Pfizer Gets FDA Priority Review of Prevnar 20 for Kids
By Colin Kellaher
Pfizer Inc. on Friday said the US Food and Drug Administration has granted priority review to its application seeking expanded approval of its Prevnar 20 vaccine for infants and children.…